Acellular Therapy Market Report 2026

Acellular Therapy Market Overview

• Acellular Therapy market size has reached to $8.3 billion in 2025 • Expected to grow to $18.09 billion in 2030 at a compound annual growth rate (CAGR) of 16.9% • Growth Driver: The Increasing Adoption Of Regenerative Medicine Fueling The Growth Of The Market Due To Expanded Research Activity And Clinical Pipeline • Market Trend: Advancements In Small Extracellular Vesicle (Sev)-Based Acellular Therapies • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Acellular Therapy Market?

Acellular therapy refers to a regenerative and therapeutic approach that uses biologically active components such as growth factors, cytokines, extracellular vesicles, or purified matrix materials instead of whole living cells to stimulate tissue repair, modulate immune responses, and promote healing. It aims to harness the beneficial effects of cellular signaling and structural support while reducing risks associated with cell transplantation, such as immune rejection, tumor formation, and complex storage or handling requirements. The main types of acellular therapy include acellular dermal matrices (ADM), acellular amniotic membranes, acellular umbilical cord products, and other types. Acellular dermal matrices (ADM) refer to biologically derived scaffolds that provide structural support and facilitate tissue regeneration without containing living cells. These therapies are used for diseases such as Parkinson’s, Alzheimer’s, chronic wounds, sclerosis, and cancer. They are applied across various scaffolds, including fused deposition modeling (FDM), cell-laden hydrogel, extracellular matrix (ECM), and selective laser sintering (SLS). The applications include hepatology, orthopedic, cardiology, neurology, oncology, and gastroenterology, and the end users are hospitals, clinics, ambulatory surgical centers, and research institutes.

What Is The Acellular Therapy Market Growth Forecast?

The acellular therapy market size is expected to see rapid growth in the next few years. It will grow to $18.09 billion in 2030 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be attributed to rising demand for personalized regenerative treatments, increasing investments in advanced biomaterials, expansion of clinical indications for acellular therapies, growing focus on scalable regenerative solutions, increasing regulatory support for non-cellular therapies. Major trends in the forecast period include increasing adoption of growth factor-based therapies, rising use of extracellular matrix scaffolds, growing focus on cell-free regenerative solutions, expansion of off-the-shelf regenerative products, enhanced integration of translational research platforms.

Global Acellular Therapy Market Segmentation

1) By Type: Acellular Dermal Matrices; Acellular Amniotic Membranes; Acellular Umbilical Cord Products; Other Types 2) By Disease: Parkinson’s; Alzheimer’s; Chronic Wounds; Sclerosis; Cancer 3) By Scaffold: Fused Deposition Modeling (FDM); Cell Laden Hydrogel; Extracellular Matrix (ECM); Selective Laser Sintering (SLS) 4) By Application: Hepatology; Orthopedic; Cardiology; Neurology; Oncology; Gastroenterology 5) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Research Institutes Subsegments: 1) By Acellular Dermal Matrices: Human Derived Dermal Matrices; Animal Derived Dermal Matrices; Cross Linked Dermal Matrices; Non Cross Linked Dermal Matrices 2) By Acellular Amniotic Membranes: Cryopreserved Amniotic Membranes; Dehydrated Amniotic Membranes; Lyophilized Amniotic Membranes; Laminated Amniotic Membranes 3) By Acellular Umbilical Cord Products: Wharton Jelly Based Products; Umbilical Cord Patch Products; Umbilical Cord Powder Products; Umbilical Cord Sheet Products 4) By Other Types: Acellular Cartilage Matrices; Acellular Bone Matrices; Acellular Vascular Grafts; Acellular Tendon And Ligament Scaffolds

What Is The Driver Of The Acellular Therapy Market?

The increasing adoption of regenerative medicine is expected to propel the growth of the acellular therapy market going forward. Regenerative medicine refers to medical approaches that repair, replace, or regenerate human cells, tissues, or organs by harnessing biological processes and therapies to restore normal function. Adoption of regenerative medicine is increasing as biotechnology research activity expands globally, with more developers, deeper pipelines, and broader therapeutic exploration. Acellular therapy (AT) supports this trend by providing bioactive, cell free therapeutic materials, such as extracellular vesicles, secretomes, and other biologically active components, that complement regenerative strategies with enhanced safety and standardized dosing. For instance, in june 2024, according to Centre for Commercialization of Regenerative Medicine (CCRM), a Canada-based regenerative medicine organization, there were 2,848 cell and gene therapy developers worldwide as of april 2024, up 11% from quarter four (Q4) 2023, and 1,751 active regenerative medicine clinical trials globally as of april 2024, reflecting sustained clinical engagement and growth in regenerative research activity. Therefore, the increasing adoption of regenerative medicine is driving the growth of the acellular therapy industry.

Key Players In The Global Acellular Therapy Market

Major companies operating in the acellular therapy market are Thermo Fisher Scientific, FUJIFILM Holdings Corp., Lonza Group AG, Smith+Nephew, Charles River Laboratories, Sartorius AG, Integra LifeSciences, AGC Biologics, Organogenesis Holdings Inc., MiMedx Group Inc., Vericel Corporation, Avita Medical, Capricor Therapeutics, RoosterBio Inc., Creative Biolabs, Evox Therapeutics Ltd., ILIAS Biologics, Aruna Biomedical, Stem Cell Medicine Ltd., Aegle Therapeutics Corp, Direct Biologics LLC., BioCardia Inc., BioRestorative Therapies Inc., and EverZom.

Global Acellular Therapy Market Trends and Insights

Major companies operating in the acellular therapy market are focusing on developing small extracellular vesicle (sEV) therapies to enhance tissue regeneration, reduce inflammation, and modulate immune responses by delivering bioactive vesicles directly to affected tissues without introducing living cells. Small extracellular vesicle (sEV) therapies refer to acellular products derived from cultured cells that carry proteins, ribonucleic acids (RNAs), and signaling molecules, enabling targeted modulation of cellular activity, repair of damaged tissue, and immunomodulation. For instance, in march 2025, evast bio, an US-based biotechnology company, developed small extracellular vesicle (sEV) therapy for knee osteoarthritis, which was designed to address key challenges in inflammatory joint disease. The therapy delivers exosomes to inflamed cartilage, promotes regeneration of cartilage extracellular matrix, reduces inflammatory markers, and improves joint function, making it a pioneering acellular therapy (AT) for musculoskeletal inflammation and a model for future extracellular vesicle (sEV) based treatments.

What Are Latest Mergers And Acquisitions In The Acellular Therapy Market?

In April 2023, AGC Biologics, a US-based global biopharmaceutical contract development and manufacturing organization (CDMO), entered into a strategic partnership with the Jikei University School of Medicine. Through this collaboration, AGC Biologics will lead a feasibility study and technology transfer to develop an exosome-based therapeutic candidate derived from bronchial epithelial cells for the treatment of idiopathic pulmonary fibrosis (IPF). Exosomes are a type of acellular therapy that deliver bioactive molecules without introducing living cells, supporting regenerative medicine and anti-inflammatory applications. The Jikei University is a Japan-based medical research institution pioneering in the development of extracellular vesicle-based therapeutics for respiratory and inflammatory diseases.

Regional Insights

North America was the largest region in the acellular therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acellular Therapy Market?

The acellular therapy market includes revenues earned by entities through regenerative medicine treatment services, immunomodulatory therapy services, aesthetic and anti-aging regenerative services, and clinical research and translational therapy services. The market value includes the value of related goods and services provided by the manufacturers or developers. Only goods and services traded between entities or sold to institutions are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Acellular Therapy Market Report 2026?

The acellular therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the acellular therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.